In addition, the two BRD4 isoforms have antagonistic roles in tumour progression and metastasis in breast cancer where BRD4-S functions as an oncogene, while BRD4-L acts as a tumour suppressor (Wu et al, 2020; Alsarraj et al, 2011). The gene discussed is BRD4; the disease is neoplasm.